IBP Stock +106.23% Since Nov ’07 Pick IBP Stock +106.23% Since Nov ’07 Pick Unlock Top Buy Picks

Range Low Price High Price Comment
30 days $16.85 $20.34 Friday, 12th Apr 2024 ACAD stock ended at $17.14. This is 1.55% less than the trading day before Thursday, 11th Apr 2024. During the day the stock fluctuated 4.54% from a day low at $16.85 to a day high of $17.62.
90 days $16.85 $29.29
52 weeks $16.85 $33.91

Historical ACADIA Pharmaceuticals Inc. prices
JSON

CSV

Date Open High Low Close Volume
2024-04-12 $17.40 $17.62 $16.85 $17.14 1 256 467
2024-04-11 $17.90 $17.90 $17.34 $17.41 1 412 418
2024-04-10 $17.72 $17.77 $17.55 $17.73 1 047 659
2024-04-09 $17.94 $18.25 $17.84 $18.15 1 300 178
2024-04-08 $17.87 $18.08 $17.63 $17.80 1 702 961
2024-04-05 $17.91 $18.25 $17.61 $18.01 1 150 767
2024-04-04 $18.52 $18.63 $18.03 $18.05 1 115 677
2024-04-03 $18.00 $18.47 $18.00 $18.42 1 322 249
2024-04-02 $18.04 $18.25 $17.86 $18.11 1 227 152
2024-04-01 $18.59 $18.59 $17.91 $18.26 1 131 227
2024-03-28 $18.20 $18.50 $18.05 $18.49 1 481 512
2024-03-27 $17.90 $18.20 $17.73 $18.20 1 622 201
2024-03-26 $17.95 $18.02 $17.68 $17.79 1 367 254
2024-03-25 $18.00 $18.18 $17.56 $17.84 1 781 975
2024-03-22 $18.34 $18.39 $17.91 $17.95 1 480 398
2024-03-21 $18.67 $19.00 $18.31 $18.41 1 929 481
2024-03-20 $18.60 $18.78 $18.30 $18.66 1 403 534
2024-03-19 $18.63 $18.91 $18.47 $18.70 1 845 378
2024-03-18 $18.59 $18.77 $18.16 $18.72 1 860 112
2024-03-15 $18.62 $18.83 $18.21 $18.48 3 560 924
2024-03-14 $19.48 $19.48 $18.55 $18.73 2 697 567
2024-03-13 $19.91 $20.34 $19.16 $19.56 2 637 720
2024-03-12 $19.49 $20.48 $19.11 $19.98 7 377 528
2024-03-11 $23.30 $24.27 $23.26 $24.13 1 463 982
2024-03-08 $23.93 $24.14 $23.22 $23.44 2 000 984
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT